breast cancer and glp 1 drugs GLP-1 cut risk by 30%? Not so fast GLP-1 Medications and Breast Cancer:

Weeks 1 through 4: 0.5 mg once weekly Weeks 5 through 8: 1 mg once weekly Weeks 9 through 12: 2 mg once weekly Weeks 13 through 16: 4 mg once weekly Weeks 17 through 20: 6 mg once weekly Weeks 21 through 24: 8 mg once weekly Weeks 25 and beyond: 10 to 12 mg once weekly (if needed and tolerated) This protocol reaches the 8 mg therapeutic range in approximately 20 weeks

Semaglutide, for example, can reduce HbA1c by up to 1.8% and weight by up to 6.5 kg

Curr Med Res Opin

J Clin Neurosci 95:172179

A recent case-control study of 1,961 new GLP-1RA patients showed that use of GLP-1RAs significantly reduced the risk of glaucoma, with a hazard ratio of 0.56 [94]

Nutr Diabetes (2012) 2:e544